- AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma- AUTO1/22: oral presentation on initial experience in r/r pediatric.
250 Pages Oncology Biosimilars Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderAccording to Fact MR’s recent market research, sales of Oncology Biosimilars to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goa.